Astera Cancer Care

Astera Cancer Care (ACC) is a prominent multispecialty physician practice established in 2021, committed to advancing cancer treatment and improving patient outcomes. With a strong emphasis on medical oncology, radiation oncology, and breast surgery, ACC has been providing comprehensive care for cancer patients in New Jersey since 1981. The organization operates across 14 distinct locations in New Jersey and Pennsylvania, including Middlesex, Somerset, Hunterdon, Mercer, Monmouth counties, and Bucks County.

Specializing in both standard and advanced therapeutics such as chemotherapy, biologic therapy, immunotherapy, and radiopharmaceuticals, ACC offers a complete portfolio of radiation oncology treatment options. Notably, the practice stands out as one of the few private groups on the East Coast to provide patients with a full array of radiation oncology treatments, including proton therapy, prostate brachytherapy, and radiosurgery.

Of significant interest is Astera's robust clinical trial platform for cancer therapy, featuring one of the few community-based clinical trial programs in CAR-T cell therapies in the nation. Furthermore, the organization has garnered recognition as a leader in value-based oncology care and alternative payment model development.

Given these impressive credentials and the growing demand for innovative cancer care, ACC presents a compelling opportunity for investment. The potential exists for further expansion, technological advancements, and pioneering research in cancer treatment, making Astera Cancer Care a promising prospect for venture capitalists seeking to support breakthroughs in the healthcare industry.